A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 18
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : LAPC
Long Form : locally advanced unresectable pancreatic cancer
No. Year Title Co-occurring Abbreviation
2019 Ablative radiation therapy for locally advanced pancreatic cancer: techniques and results. BED, CBCT, SBRT
2019 Clinical Outcomes of Conversion Surgery after Neoadjuvant Chemotherapy in Patients with Borderline Resectable and Locally Advanced Unresectable Pancreatic Cancer: A Single-Center, Retrospective Analysis. BRPC, DFS, NACT, OS
2019 Safety of radiofrequency ablation in patients with locally advanced, unresectable pancreatic cancer: A phase II study. DGE, RCT, RFA
2018 Dose escalation for locally advanced pancreatic cancer: How high can we go? DE-IMRT, OAR
2018 FOLFIRINOX and radiotherapy for locally advanced pancreatic cancer: A cohort study. CI, OS, PFS, RT
2018 Optimal resection area for superior mesenteric artery nerve plexuses after neoadjuvant chemoradiotherapy for locally advanced pancreatic carcinoma. NAC, pl-SMA
2017 Analysis of Predictors of Resection and Survival in Locally Advanced Stage III Pancreatic Cancer: Does the Nature of Chemotherapy Regimen Influence Outcomes? HR, MVA, OS
2016 ARCII: A phase II trial of the HIV protease inhibitor Nelfinavir in combination with chemoradiation for locally advanced inoperable pancreatic cancer. CRT, OS, PFS
2016 Contemporary Management of Borderline Resectable and Locally Advanced Unresectable Pancreatic Cancer. BRPC
10  2016 Hypofractionated ablative radiotherapy for locally advanced pancreatic cancer. CT, SBRT
11  2013 Change in CA 19-9 levels after chemoradiotherapy predicts survival in patients with locally advanced unresectable pancreatic cancer. CRT
12  2013 Complete pathological remission of locally advanced, unresectable pancreatic cancer (LAPC) after intensified neoadjuvant chemotherapy. nab, pCR
13  2013 Duodenal toxicity after fractionated chemoradiation for unresectable pancreatic cancer. ---
14  2012 The GOFURTGO Study: AGITG phase II study of fixed dose rate gemcitabine-oxaliplatin integrated with concomitant 5FU and 3-D conformal radiotherapy for the treatment of localised pancreatic cancer. 5-FU, LC, PFS
15  2012 Treatment of locally advanced unresectable pancreatic cancer: a 10-year experience. CRT, OS, PFS
16  2011 Regional hyperthermia combined with chemoradiotherapy in primary or recurrent locally advanced pancreatic cancer : an open-label comparative cohort trial. CRT, CT, GEM, HT, OS, RT
17  2009 Long-term results of concurrent radiotherapy and UFT in patients with locally advanced pancreatic cancer. CRT
18  2007 Chemotherapy as initial treatment of locally advanced unresectable pancreatic cancer: a valid option? ---